Summary
Thermo Fisher Scientific Inc. (TMO) hosted a virtual Investor Meeting on September 16, 2021, to discuss future performance expectations. The company provided guidance for 2022, projecting revenue of $40.3 billion and adjusted Earnings Per Share (EPS) of $21.16. Management emphasized that these are estimates and actual results may vary due to ongoing market uncertainties. The filing also clarified Thermo Fisher's use of non-GAAP financial measures, specifically adjusted EPS. This measure excludes certain costs such as acquisition-related expenses, restructuring charges, and amortization of intangible assets, which management believes provides a clearer view of the company's core operating performance and future prospects. Investors should note that GAAP measures are not provided on a forward-looking basis due to the unpredictability of certain exclusion items.
Key Highlights
- 1Thermo Fisher provided 2022 revenue guidance of $40.3 billion.
- 2The company anticipates 2022 adjusted EPS to be $21.16.
- 3Forward-looking estimates are subject to market uncertainties and actual results may differ.
- 4Investor Meeting included presentations on future performance expectations by senior management.
- 5The company reiterated its use of non-GAAP financial measures, particularly adjusted EPS, to illustrate core operating performance.
- 6Adjusted EPS excludes acquisition-related costs, restructuring charges, and amortization of intangibles.